Overview

A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder

Status:
Completed
Trial end date:
2008-01-10
Target enrollment:
Participant gender:
Summary
To compare by neuroimaging techniques and public speaking, the way social anxiety patients respond after the administration of GW876008, GSK561679, alprazolam and placebo
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Alprazolam
Anti-Anxiety Agents